Please use this identifier to cite or link to this item: https://doi.org/10.1155/2016/6958293
DC FieldValue
dc.titlePotential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination
dc.contributor.authorLim, Pei Wen
dc.contributor.authorGarssen, Johan
dc.contributor.authorSandalova, Elena
dc.date.accessioned2022-06-09T04:29:00Z
dc.date.available2022-06-09T04:29:00Z
dc.date.issued2016
dc.identifier.citationLim, Pei Wen, Garssen, Johan, Sandalova, Elena (2016). Potential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination. Mediators of Inflammation 2016 : 1-12. ScholarBank@NUS Repository. https://doi.org/10.1155/2016/6958293
dc.identifier.issn0962-9351,1466-1861
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/226852
dc.description.abstract<jats:p>Vaccination, designed to trigger a protective immune response against infection, is a trigger for mild inflammatory responses. Vaccination studies can address the question of inflammation initiation, levels, and resolution as well as its regulation for respective studied pathogens. Such studies largely based on analyzing the blood components including specific antibodies and cytokines were usually constrained by number of participants and volume of collected blood sample. Hence, blood-based studies may not be able to cover the full dynamic range of inflammation responses induced by vaccination. In this review, the potential of using saliva in addition to blood for studying the kinetics of inflammatory response studies was assessed. Saliva sampling is noninvasive and has a great potential to be used for studies aimed at analysing the magnitude, time course, and variance in immune responses, including inflammation after vaccination. Based on a literature survey of inflammatory biomarkers that can be determined in saliva and an analysis of how these biomarkers could help to understand the mechanisms and dynamics of immune reactivity and inflammation, we propose that the saliva-based approach might have potential to add substantial value to clinical studies, particularly in vulnerable populations such as infants, toddlers, and ill individuals.</jats:p>
dc.publisherHindawi Limited
dc.sourceElements
dc.typeArticle
dc.date.updated2022-06-07T04:16:00Z
dc.contributor.departmentMEDICINE
dc.description.doi10.1155/2016/6958293
dc.description.sourcetitleMediators of Inflammation
dc.description.volume2016
dc.description.page1-12
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Lim-.pdf1.34 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

13
checked on Dec 2, 2022

Page view(s)

44
checked on Dec 1, 2022

Download(s)

2
checked on Dec 1, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.